Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus FedEx Corporation FDX Institutional Value Strategy Unveils New Position In Global Logistics Leader CODI Compass Div blows past Q4 2025 EPS estimates by 5486 percent shares rise 044 percent today ONFOW Onfolio withholds formal quarterly earnings metrics set to share operational updates at its upcoming investor briefing Hyperion DeFi HYPD Complete Analysis Q4 2025 EPS Misses Views